Commentary on de Vos etal. (2013): Can ecological trends in HIV or HCV incidence be used to assess intervention impact?

Addiction

Volumn 108, Issue 6, 2013, Pages 1082-1083

  Vickerman, Peter ^a   Hickman, Matthew ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Community viral load; HCV; HIV; Incidence; Modelling; People who inject drugs

Indexed keywords

HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; SUBSTANCE ABUSE; HEPATITIS C, CHRONIC; HIV INFECTIONS;

HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84877638084     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12206     Document Type: Note

References (19)

1. van Den Berg C. H., Smit C., Bakker M., Geskus R. B., Berkhout B., Jurriaans S. etal. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur J Epidemiol 2007; 22: 183-193.
2. Hurley S. F., Jolley D. J., Kaldor J. M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797-1800.
3. Des Jarlais D. C., Feelemyer J. P., Modi S. N., Abdul-Quader A., Hagan H. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health 2013; 13: 53.
4. Hallett T. B., Gregson S., Mugurungi O., Gonese E., Garnett G. P. Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to Zimbabwe. Epidemics 2009; 1: 108-117.
5. Boily M. C., Pickles M., Lowndes C. M., Ramesh B. M., Washington R., Moses S. etal. Positive impact of a large-scale HIV prevention program among female sex workers and clients in Karnataka state, India. AIDS 2013; Epub ahead of print.
6. Barrio G., Bravo M. J., Brugal M. T., Diez M., Regidor E., Belza M. J. etal. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. Addiction 2012; 107: 1111-1122.
7. Smith G. D. Commentary: behind the Broad Street pump: aetiology, epidemiology and prevention of cholera in mid-19th century Britain. Int J Epidemiol 2002; 31: 920-932.
8. de Vos A. S., van der Helm J. J., Matser A., Prins M., Kretzschmar M. E. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? Addiction 2013; 108: 1070-1081.
9. Hagan H., Pouget E. R., Des Jarlais D. C. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis 2011; 204: 74-83.
10. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction 2010; 105: 844-859.
11. MacArthur G. J., Minozzi S., Martin N., Vickerman P., Bruneau J., Davoli M. etal. Evidence for the effectiveness of opiate substitution treatment in relation to HIV transmission in people who inject drugs: a systematic review and meta-analysis. BMJ; 2012; 345: 1-16.
12. Turner K., Hutchinson S., Vickerman P., Hope V., Craine N., Palmateer N. etal. The impact of needle and syringe provision and opiate substitution therapy on the incidence of Hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction 2011; 106: 1978-1988.
13. Wood E., Kerr T., Marshall B. D., Li K., Zhang R., Hogg R. S. etal. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009; 338: b1649.
14. Mehta S. H., Astemborski J., Kirk G. D., Strathdee S. A., Nelson K. E., Vlahov D. etal. Changes in blood-borne infection risk among injection drug users. J Infect Dis 2011; 203: 587-594.
15. Kirk G., Galai N., Astemborski J., Linas B., Celentano D., Mehta S. etal. Decline in community viral load strongly associated with decline HIV incidence among IDU. In: Conference on Retroviruses and Opportunistic Infections. Boston, USA; 2011.
16. Bruneau J., Daniel M., Abrahamowicz M., Zang G., Lamothe F., Vincelette J. Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study. Am J Epidemiol 2011; 173: 1049-1058.
17. Des Jarlais D. C., Perlis T., Arasteh K., Torian L. V., Beatrice S., Milliken J. etal. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health 2005; 95: 1439-1444.
18. Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS. Drug Situation in Vancouver. Vancouver, Canada; 2009.
19. Mills H. L., Colijn C., Vickerman P., Leslie D., Hope V., Hickman M. Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK. Drug Alcohol Depend 2012; 126: 324-332.